Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism by Thomas Holly R, Ezzeldin Hany H, Guarcello Vincenzo, Mattison Lori K, Fridley Brooke L, Diasio Robert B in Pharmacogenetics and genomics (2007).

[PMID: 18075467] PubMed


Dihydropyrimidine dehydrogenase (DPD) deficiency accounts for approximately 43% of grade 3-4 toxicity to 5-fluorouracil. There, however, remain a number of patients presenting with 5-fluorouracil-associated toxicity despite normal DPD enzyme activity, suggesting possible deficiencies in dihydropyrimidinase (DHP), encoded by the DPYS gene, and/or beta-ureidopropionase (BUP-1), encoded by the UPB1 gene. This study investigates the role of DPYS sequence variations in individuals with unexplained molecular basis of altered uracil catabolism.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.